Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK
<p>Summary: The venous thromboembolism risk among anti-osteoporotics is unknown. In this primary care study, the risk with other bisphosphonates [1.05 (0.94–1.18) and 0.96 (0.78–1.18)], strontium [0.90 (0.61–1.34) and 1.19 (0.82–1.74)], in the UK and Spain respectively, and denosumab [1.77 (0....
Autors principals: | Martín-Merino, E, Petersen, I, Hawley, S, Álvarez-Gutierrez, A, Khalid, S, Llorente-Garcia, A, Delmestri, A, Javaid, M, Van Staa, T, Judge, A, Cooper, C, Prieto-Alhambra, D |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
Springer Verlag
2017
|
Ítems similars
-
Risk of venous thromboembolism amongst users of different anti-osteoporosis drugs: a multinational population-based cohort study
per: Martin-Merino, E, et al.
Publicat: (2016) -
Risk of venous thromboembolism amongst users of different antiosteoporosis drugs: a multinational population-based cohort study
per: Martin-Merino, E, et al.
Publicat: (2016) -
200,000 students go to polls today.
per: Kapoor, Carisma
Publicat: (2012) -
“You paid 200,000 francs for this shit?”
per: James Murdoch
Publicat: (2023-04-01) -
UPM kumpul RM200,000 untuk kanser
per: Universiti Putra Malaysia
Publicat: (2005)